Terms: = Bone cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Prognosis
43 results:
1. Establishment and Characterization of Cell Lines from Canine Metastatic Osteosarcoma.
Yang YT; Engleberg AI; Yuzbasiyan-Gurkan V
Cells; 2023 Dec; 13(1):. PubMed ID: 38201229
[TBL] [Abstract] [Full Text] [Related]
2. PROGNOSTIC IMPLICATIONS OF PD-L1 EXPRESSION AND LOSS OF pten IN PATIENTS WITH RHABDOMYOSARCOMA, EWING'S SARCOMA AND OSTEOSARCOMA.
Abd Elmoneim HM; Huwait HF; Nafady-Hego H; Mohamed FA
Exp Oncol; 2023 Dec; 45(3):337-350. PubMed ID: 38186021
[TBL] [Abstract] [Full Text] [Related]
3. New emerging targets in osteosarcoma therapy: pten and PI3K/Akt crosstalk in carcinogenesis.
Sadrkhanloo M; Paskeh MDA; Hashemi M; Raesi R; Bahonar A; Nakhaee Z; Entezari M; Beig Goharrizi MAS; Salimimoghadam S; Ren J; Nabavi N; Rashidi M; Dehkhoda F; Taheriazam A; Tan SC; Hushmandi K
Pathol Res Pract; 2023 Nov; 251():154902. PubMed ID: 37922723
[TBL] [Abstract] [Full Text] [Related]
4. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
5. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
6. An Immunohistochemical Study of Breast cancer Brain Metastases: The Role of CD44 and AKT in the prognosis.
Martins Gama J; Caetano Oliveira R; Teixeira P; Silva F; Abrantes C; Figueiredo P; Simões S; Rebelo O; Cipriano MA
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):318-323. PubMed ID: 37093706
[TBL] [Abstract] [Full Text] [Related]
7. PINK1 regulates apoptosis of osteosarcoma as the target gene of cisplatin.
Si Z; Shen Z; Luan F; Yan J
J Orthop Surg Res; 2023 Feb; 18(1):132. PubMed ID: 36823640
[TBL] [Abstract] [Full Text] [Related]
8. Non-canonical EphA2 activation underpins pten-mediated metastatic migration and poor clinical outcome in prostate cancer.
Sachdeva A; Hart CA; Kim K; Tawadros T; Oliveira P; Shanks J; Brown M; Clarke N
Br J Cancer; 2022 Oct; 127(7):1254-1262. PubMed ID: 35869144
[TBL] [Abstract] [Full Text] [Related]
9. MicroRNA-181a-5p Promotes Osteosarcoma Progression via pten/AKT Pathway.
Sun C; Chen C; Chen Z; Guo J; Yu ZH; Qian W; Ai F; Xiao L; Guo X
Anal Cell Pathol (Amst); 2022; 2022():3421600. PubMed ID: 35310933
[TBL] [Abstract] [Full Text] [Related]
10. A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with pten, RB1 and TP53 alterations.
Kobayashi H; Kosaka T; Nakamura K; Shojo K; Hongo H; Mikami S; Nishihara H; Oya M
BMC Med Genomics; 2021 Oct; 14(1):245. PubMed ID: 34627261
[TBL] [Abstract] [Full Text] [Related]
11. Targeted Next-Generation Sequencing Reveals Heterogenous Genomic Features in Viscerally Metastatic Prostate cancer.
Gong Y; Fan L; Fei X; Zhu Y; Du X; He Y; Pan J; Dong B; Xue W
J Urol; 2021 Aug; 206(2):279-288. PubMed ID: 33780283
[TBL] [Abstract] [Full Text] [Related]
12. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
[TBL] [Abstract] [Full Text] [Related]
13. pten in osteosarcoma: Recent advances and the therapeutic potential.
Zheng C; Tang F; Min L; Hornicek F; Duan Z; Tu C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188405. PubMed ID: 32827577
[TBL] [Abstract] [Full Text] [Related]
14. FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting pten activity.
Wu W; Jing D; Meng Z; Hu B; Zhong B; Deng X; Jin X; Shao Z
Theranostics; 2020; 10(6):2859-2871. PubMed ID: 32194840
[No Abstract] [Full Text] [Related]
15. CCN1 stimulated the osteoblasts via pten/AKT/GSK3β/cyclinD1 signal pathway in Myeloma bone Disease.
Yan S; Liu H; Liu Z; Peng F; Jiang F; Li L; Fu R
Cancer Med; 2020 Jan; 9(2):737-744. PubMed ID: 31769620
[TBL] [Abstract] [Full Text] [Related]
16. Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer.
Bi CW; Zhang GY; Bai Y; Zhao B; Yang H
Medicine (Baltimore); 2019 Sep; 98(36):e16705. PubMed ID: 31490362
[TBL] [Abstract] [Full Text] [Related]
17. Association between pten and clinical-pathological features of osteosarcoma.
Zhou J; Xiao X; Wang W; Luo Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31270249
[TBL] [Abstract] [Full Text] [Related]
18. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract] [Full Text] [Related]
19. SLC25A22 Promotes Proliferation and Metastasis of Osteosarcoma Cells via the pten Signaling Pathway.
Chen MW; Wu XJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818811143. PubMed ID: 30482097
[TBL] [Abstract] [Full Text] [Related]
20. MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis.
Ikeda S; Schwaederle M; Mohindra M; Fontes Jardim DL; Kurzrock R
J Hematol Oncol; 2018 Jun; 11(1):76. PubMed ID: 29866143
[TBL] [Abstract] [Full Text] [Related]
[Next]
